Results for “ ”

Entry Author Date Location
Imara Dives Into Coronavirus-Churned Financial Waters With a $75M IPO 03/12/20 Boston
Kymera Closes $102M Round to Bring Protein-Busting Drugs to the Clinic 03/12/20 Boston
Xcelerating Life Sciences San Diego Will Be Delivered Digitally 03/11/20 National
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund 03/11/20 Europe
Silverback Therapeutics Adds $79M to Test HER2+ Tumor-Targeting Drug 03/11/20 Seattle
Acceleron Drops Drug for Rare Muscle Disease After Mixed Phase 2 Data 03/10/20 Boston
Kala to Take Another Shot at FDA Approval With New Dry Eye Drug Data 03/09/20 Boston
Cushing’s Disease Drug That Novartis Sold to Recordati Nabs FDA Nod 03/09/20 Europe
Zentalis Leads a Trio of Biotechs Charting a Course for Wall Street 03/09/20 New York
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
Roche Trial of Ionis Huntington’s Disease Drug Halted After Side Effects 03/05/20 San Diego
Culture Biosciences Adds $15M for New Software, Bioreactor Expansion 03/05/20 San Francisco
Melinta’s Chapter 11 Auction Draws No Bids, Deerfield to Get Assets 03/04/20 New York
Amunix Raises $73M to Bring Safer T Cell Engagers to Solid Tumors 03/04/20 San Francisco
Court Rules More Trial Data Must Be Posted On ClinicalTrials.gov 03/04/20 National
Novartis Leads $100M Round for Fibrosis-Focused Pliant Therapeutics 03/03/20 San Francisco
Sanofi Wins FDA Nod for Combo Therapy in Multiple Myeloma 03/03/20 National
National Xconomy Awards Now Accepting Nominations for the Best in Biotech 03/03/20 National
Gilead Boosts Cancer Drug Pipeline With $4.9B Deal for Forty Seven 03/02/20 San Francisco
ORIC Pharma Plans IPO to Test Therapies for Drug-Resistant Cancers 03/02/20 San Francisco
Xilio Unveils New Name, $100M to Bring Targeted Cancer Drugs to Clinic 03/02/20 Boston
Biogen, Sangamo Ink Neuro Deal for New “Gene Regulation” Therapies 02/28/20 National
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
Passage Bio’s IPO Raises $216M to Fund Gene Therapy Studies 02/28/20 National
Biohaven’s Migraine Pill Is the Latest CGRP Drug to Win the FDA’s OK 02/27/20 New York
Gilead, Moderna Candidates Ramp Up Coronavirus Drug, Vaccine Testing 02/27/20 National
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod 02/26/20 Detroit Ann Arbor
Takeda Bases PvP Biologics Buyout on Promising Early Celiac Drug Data 02/26/20 San Diego
With Foamix Merger Weeks Away, Menlo Itching Drug Fails a Phase 2 Test 02/26/20 San Francisco
Bicycle Therapeutics Lands $30M From Genentech in New Cancer R&D Pact 02/25/20 Boston
Page 2 of 388 « previous page · next page »